首页> 外文期刊>The Open Cardiovascular Medicine Journal >Evaluation of Glycemia Control Achieved by Glargine and Lispro Versus Detemir and Aspart Insulin Regimes in Type 2 Diabetics Undergoing Surgery
【24h】

Evaluation of Glycemia Control Achieved by Glargine and Lispro Versus Detemir and Aspart Insulin Regimes in Type 2 Diabetics Undergoing Surgery

机译:甘精胰岛素和赖脯胰岛素与德特米尔和门冬胰岛素治疗2型糖尿病患者的血糖控制评估

获取原文
       

摘要

There is paucity of scientific literature regarding the clinical outcome of long lasting basal insulin and rapid acting mealtime insulin regimes in surgical situations although employed in non-surgical situations. This study has evaluated the clinical outcome of two subcutaneous split-mixed Glargine+Lispro and Detemir+Aspart insulin regimes in type 2 diabetics undergoing surgery.
机译:尽管在非手术情况下使用了长期的基础胰岛素和快速作用的进餐时间胰岛素治疗的临床结果,但缺乏科学文献。这项研究评估了在接受手术治疗的2型糖尿病患者中,两种皮下注射混合的Glargine + Lispro和Detemir + Aspart胰岛素治疗的临床效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号